WOONSOCKET, R.I., March 16, 2017 /PRNewswire/ -- CVS Health
(NYSE: CVS) today announced the company will launch Reduced Rx™, a
prescription savings program that will offer discounts on certain
medications – through CVS Health's pharmacy benefits manager, CVS
Caremark – directly to patients. The program will help
patients with high out of pocket costs afford essential
medications. Novo Nordisk will participate in the
prescription savings program. Through this program, CVS
Health and Novo Nordisk will offer Novolin R®, Novolin N® and
Novolin 70/30® human insulin at a cost of $25 per 10ml vial, which reflects a potential
savings of as much as $100 for cash
paying patients.
The Reduced Rx launch follows another affordability announcement
made earlier this year by CVS Health. Working with Impax
Laboratories, CVS Health announced in January that it has made the
authorized generic for Adrenaclick, an epinephrine auto-injector
for patients with allergic reactions, available at all CVS Pharmacy
locations at the lowest cash price in the market, $109.99 for a two-pack. CVS Health
collaborated to create both the generic Adrenaclick offering and
the Reduced Rx program in response to consumer need for low cost
options.
"We developed the Reduced Rx prescription savings program with
Novo Nordisk because we both recognized a need and an opportunity
to make critical medications more affordable for patients," said
Jonathan Roberts, Executive Vice
President and Chief Operating Officer, CVS Health. "This
savings program will leverage CVS Caremark's expertise in providing
lower cost prescription drugs and fulfill our company's purpose of
helping people on their path to better health."
"This program underscores how important collaboration is to
addressing the affordability challenges patients face in certain
health plans or who remain uninsured. We all have a role to
play and that's why we welcomed the chance to work with CVS Health
on this program," said Doug Langa,
senior vice president and head of North America Operations,
Novo Nordisk. "We're committed to
developing sustainable solutions with customers and will continue
to pursue opportunities to ensure that patients have access to
insulin that is affordable."
"With nearly ten percent of the U.S. population living with
diabetes, ensuring patients have access to affordable insulin is
more important than ever," said Troyen Brennan, M.D., Executive
Vice President and Chief Medical Officer, CVS Health. "We're
pleased that our Reduced Rx prescription savings program can help
assure that effective medications are also affordable."
Reduced Rx will allow patients to purchase medications at a
reduced cost at any of the more than 67,000 pharmacies in the CVS
Caremark retail network, including the more than 9,700 CVS Pharmacy
locations throughout the U.S. Patients using the Reduced Rx
prescription savings program will need to pay the cost of the
medication out of pocket; the program cannot be used with any
prescription drug insurance coverage. Patients can learn more
about the Reduced Rx savings program at www.ReducedRx.com or by
calling toll free 1-844-379-1668. Patient enrollment in the
program will begin in May 2017. Following its initial
offering with Novo Nordisk, CVS Health intends to expand the
Reduced Rx prescription savings program to other medications and to
address other conditions.
About CVS Health
CVS Health is a pharmacy innovation
company helping people on their path to better health. Through its
more than 9,700 retail locations, more than 1,100 walk-in medical
clinics, a leading pharmacy benefits manager with nearly 90 million
plan members, a dedicated senior pharmacy care business serving
more than one million patients per year, expanding specialty
pharmacy services, and a leading stand-alone Medicare Part D
prescription drug plan, the company enables people, businesses and
communities to manage health in more affordable and effective ways.
This unique integrated model increases access to quality care,
delivers better health outcomes and lowers overall health care
costs. Find more information about how CVS Health is shaping the
future of health at https://www.cvshealth.com.
About Novo Nordisk
Novo Nordisk is a global health
care company with more than 90 years of innovation and leadership
in diabetes care. This heritage has given us experience and
capabilities that also enable us to help people defeat other
serious chronic conditions: hemophilia, growth disorders and
obesity. With U.S. headquarters in Plainsboro, N.J., Novo Nordisk Inc. has nearly
5,000 employees in the United
States. For more information, visit www.novonordisk.us or
follow us on Twitter: @novonordiskus.
Media Contacts:
Erin Shields Britt
CVS Health Corporate Communications
(401) 770-9237
Erin.Britt@CVSHealth.com
Ken Inchausti
Novo Nordisk
(609) 786-8316
kiau@novonordisk.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/cvs-health-launches-reduced-rx-savings-program-to-give-patients-access-to-more-affordable-medications-300424627.html
SOURCE CVS Health